NATIENS: Optimal Management and Mechanisms of SJS/TEN

NCT02987257 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Stevens-Johnson Syndrome
Toxic Epidermal Necrolyses

Interventions

DRUG: Harmonized supportive care
DRUG: Etanercept 50 mg sc day 1 and day 4

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]